Drug and Gene Delivery Systems Market Global Industry Analysis, Share, Size, Growth, Trends and Forecast 2017 - 2025

Mar 2018| TMR333A| Transparency

Report Highlights

Drug and Gene Delivery Systems Market: Overview

Drug delivery includes formulations, technologies, methods, and systems used for transferring an active pharmaceutical ingredient into the body as desired, in order to safely accomplish its therapeutic effect. Gene delivery is a procedure employed to introduce foreign DNA into host cells. Rising prevalence of chronic diseases such as cancer and diabetes is increasing the demand for drug and gene delivery systems. According to JAMA Oncology, around 17.5 million new cancer cases were reported across the world in 2015. According to a WHO report published in 2017, around 1.0 million people died of HIV infection across the globe in 2016. Several advancements have been made in the field of drug and gene delivery systems such as nanoparticle technology, Prodrug formulation, liposomes & hydrogels, particle engineering & particulate systems, and three-dimensional printing (3DP) in order to attain sustained and controlled release of drugs.

Drug and Gene Delivery Systems Market: Segmentation

The drug and gene delivery systems market has been segmented in terms of delivery system, route of administration, application, and geography. Based on delivery system, the market has been segmented into drug delivery systems and gene delivery systems. The drug delivery systems segment has been sub-segmented into intrauterine implants, Prodrug implants, polymeric drug delivery, and targeted drug delivery. The gene delivery systems segment has been sub-segmented into viral gene delivery, non-viral gene delivery, and combined hybrid system. The viral gene delivery sub-segment has been further classified into adenovirus vector, lentivirus vector, retrovirus vector, adeno-associated virus vector, Sendai virus vector, herpes simplex virus vector, and others. The non-viral gene delivery sub-segment has been further classified into natural organic compounds, physical methods, and chemical methods. Based on route of administration, the market has been segmented into oral, injectable, inhalation, transdermal, ocular, nasal, and topical. In terms of application, the market has been divided into infectious diseases, oncology, ophthalmology, urology, diabetes, CNS, and others. Based on geography, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

The research is a combination of primary and secondary research, which has been conducted for understanding and arriving at trends and used to forecast the revenue expected to be generated in the global drug and gene delivery systems market in the near future. Primary research represents a bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key market experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentations, and various international and national databases. The report provides estimated market size (in US$ Bn) of segments based on delivery system, route of administration, application, and geography for the period from 2015 to 2025, considering the macro and micro environmental factors. The revenue generated by each of these segments was calculated by considering the drug and gene delivery system market product sales.

The report comprises an elaborate executive summary which includes market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to segments based on delivery system, route of route of administration, application, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints, and opportunities that influence the drug and gene delivery systems market. The report also provides Porter’s five forces analysis, the acquisitions timeline of drug and gene delivery systems market companies, SWOT analysis of the market, regulatory scenario, and comparative analysis of the drug and gene delivery systems market policies.

Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors would help market players decide about their business strategies and plans in order to strengthen their position in the global market. Based on geography, the market has been categorized into regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The study also covers detailed country analysis contributing majorly in the drug and gene delivery systems market.

The report also profiles major players operating in the drug and gene delivery systems market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Companies profiled in the report are Oxford BioMedica, Pfizer, Inc., Amgen Inc., Astrazeneca plc, Bayer AG, SiBiono GeneTech Co., Shanghai Sunway Biotech Co., Ltd., Human Stem Cells Institute, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Novartis AG, and Becton, Dickinson and Company.

The drug and gene delivery systems market has been segmented as follows:

Drug and Gene Delivery Systems Market, by Delivery System

Drug Delivery Systems
Intrauterine Implants
Prodrug Implants
Polymeric Drug Delivery
Targeted Drug Delivery
Gene Delivery Systems
Viral Gene Delivery
Adenovirus Vector
Lentivirus Vector
Retrovirus Vector
Adeno-associated Virus Vector
Sendai Virus Vector
Herpes Simplex Virus Vector
Others
Non-viral Gene Delivery
Natural Organic Compounds
Physical Methods
Chemical Methods
Combined Hybrid System

Drug and Gene Delivery Systems Market, by Route of Administration

Oral
Injectable
Inhalation
Transdermal
Ocular
Nasal
Topical

Drug and Gene Delivery Systems Market, by Application

Infectious Diseases
Oncology
Ophthalmology
Urology
Diabetes
CNS
Others

Drug and Gene Delivery Systems Market, by Geography

Drug and Gene Delivery Systems Market, by Geography
North America
U.S.
Canada
Europe
U.K.
Germany
Spain
France
Italy
Rest of Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of LATAM
Middle East & Africa
GCC
South Africa
Israel
Rest of MEA

  • Table 1 : Regulatory Scenario in Different Countries
  • Table 2 : Gene Therapy Pipeline Molecules
  • Table 3 : Drug Therapy Pipeline Products
  • Table 4 : Global Drug and Gene Delivery Systems Market Size (US$ Bn) Forecast, by Drug Delivery System, 2015–2025
  • Table 5 : Global Drug and Gene Delivery Systems Market Size (US$ Mn) Forecast, by Gene Delivery System, 2015–2025
  • Table 6 : Global Drug and Gene Delivery Systems Market Size (US$ Mn) Forecast, by Gene Delivery System: Viral Gene Delivery, 2015–2025
  • Table 7 : Global Drug and Gene Delivery Systems Market Size (US$ Mn) Forecast, by Gene Delivery System: Non-viral Gene Delivery, 2015–2025
  • Table 8 : Global Drug Delivery System Market Value (US$ Bn) Forecast, by Application, 2015–2025
  • Table 9 : Global Gene Delivery System Market Value (US$ Mn) Forecast, by Application, 2015–2025
  • Table 10 : Global Drug and Gene Delivery Systems Market Value (US$ Bn) Forecast, by Drug Delivery: Route of Administration, 2015–2025
  • Table 11 : Global Drug and Gene Delivery Systems Market Value (US$ Mn) Forecast, by Gene Delivery: Route of Administration, 2015–2025
  • Table 12 : Global Drug and Gene Delivery System Market Size (US$ Bn) Forecast, by Region, 2015–2025
  • Table 13 : North America Drug Delivery System Market Size (US$ Bn) Forecast, by Country, 2015–2025
  • Table 14 : North America Gene Delivery System Market Size (US$ Mn) Forecast, by Country, 2015–2025
  • Table 15 : North America Drug and Gene Delivery System Market Size (US$ Bn) Forecast, by Drug Delivery System, 2015–2025
  • Table 16 : North America Drug and Gene Delivery System Market Size (US$ Mn) Forecast, by Gene Delivery System, 2015–2025
  • Table 17 : North America Gene Delivery System Market Size (US$ Mn) Forecast, by Viral Gene Delivery, 2015–2025
  • Table 18 : North America Gene Delivery System Market Size (US$ Mn) Forecast, by Non-viral Gene Delivery, 2015–2025
  • Table 19 : North America Drug Delivery System Market Size (US$ Bn) Forecast, by Application, 2015–2025
  • Table 20 : North America Gene Delivery System Market Size (US$ Mn) Forecast, by Application, 2015–2025
  • Table 21 : North America Drug Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
  • Table 22 : North America Gene Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
  • Table 23 : Europe Drug Delivery System Market Size (US$ Bn) Forecast, by Country/Sub-region, 2015–2025
  • Table 24 : Europe Gene Delivery System Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 25 : Europe Drug and Gene Delivery System Market Size (US$ Bn) Forecast, by Drug Delivery System, 2015–2025
  • Table 26 : Europe Drug and Gene Delivery System Market Size (US$ Mn) Forecast, by Gene Delivery System, 2015–2025
  • Table 27 : Europe Gene Delivery System Market Size (US$ Mn) Forecast, by Viral Gene Delivery, 2015–2025
  • Table 28 : Europe Gene Delivery System Market Size (US$ Mn) Forecast, by Non-viral Gene Delivery, 2015–2025
  • Table 29 : Europe Drug Delivery System Market Size (US$ Bn) Forecast, by Application, 2015–2025
  • Table 30 : Europe Gene Delivery System Market Size (US$ Mn) Forecast, by Application, 2015–2025
  • Table 31 : Europe Drug Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
  • Table 32 : Europe Gene Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
  • Table 33 : Asia Pacific Drug Delivery System Market Size (US$ Bn) Forecast, by Country/Sub-region, 2015–2025
  • Table 34 : Asia Pacific Gene Delivery System Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 35 : Asia Pacific Drug and Gene Delivery System Market Size (US$ Bn) Forecast, by Drug Delivery System, 2015–2025
  • Table 36 : Asia Pacific Drug and Gene Delivery System Market Size (US$ Mn) Forecast, by Gene Delivery System, 2015–2025
  • Table 37 : Asia Pacific Gene Delivery System Market Size (US$ Mn) Forecast, by Viral Gene Delivery, 2015–2025
  • Table 38 : Asia Pacific Gene Delivery System Market Size (US$ Mn) Forecast, by Non-viral Gene Delivery, 2015–2025
  • Table 39 : Asia Pacific Drug Delivery System Market Size (US$ Bn) Forecast, by Application, 2015–2025
  • Table 40 : Asia Pacific Gene Delivery System Market Size (US$ Mn) Forecast, by Application, 2015–2025
  • Table 41 : Asia Pacific Drug Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
  • Table 42 : Asia Pacific Gene Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
  • Table 43 : Latin America Drug Delivery System Market Size (US$ Bn) Forecast, by Country/Sub-region, 2015–2025
  • Table 44 : Latin America Gene Delivery System Market Size (US$ Bn) Forecast, by Country/Sub-region, 2015–2025
  • Table 45 : Latin America Drug and Gene Delivery System Market Size (US$ Bn) Forecast, by Drug Delivery System, 2015–2025
  • Table 46 : Latin America Drug and Gene Delivery System Market Size (US$ Mn) Forecast, by Gene Delivery System, 2015–2025
  • Table 47 : Latin America Gene Delivery System Market Size (US$ Mn) Forecast, by Viral Gene Delivery, 2015–2025
  • Table 48 : Latin America Gene Delivery System Market Size (US$ Mn) Forecast, by Non-viral Gene Delivery, 2015–2025
  • Table 49 : Latin America Drug Delivery System Market Size (US$ Bn) Forecast, by Application, 2015–2025
  • Table 50 : Latin America Gene Delivery System Market Size (US$ Mn) Forecast, by Application, 2015–2025
  • Table 51 : Latin America Drug Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
  • Table 52 : Latin America Gene Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
  • Table 53 : Middle East & Africa Drug Delivery System Market Size (US$ Bn) Forecast, by Country/Sub-region, 2015–2025
  • Table 54 : Middle East & Africa Gene Delivery System Market Size (US$ Bn) Forecast, by Country/Sub-region, 2015–2025
  • Table 55 : Middle East & Africa Drug and Gene Delivery System Market Size (US$ Bn) Forecast, by Drug Delivery System, 2015–2025
  • Table 56 : Middle East & Africa Drug and Gene Delivery System Market Size (US$ Mn) Forecast, by Gene Delivery System, 2015–2025
  • Table 57 : Middle East & Africa Gene Delivery System Market Size (US$ Mn) Forecast, by Viral Gene Delivery, 2015–2025, 2015–2025
  • Table 58 : Middle East & Africa Gene Delivery System Market Size (US$ Mn) Forecast, by Non-viral Gene Delivery, 2015–2025
  • Table 59 : Middle East & Africa Drug Delivery System Market Size (US$ Bn) Forecast, by Application, 2015–2025
  • Table 60 : Middle East & Africa Gene Delivery System Market Size (US$ Mn) Forecast, by Application, 2015–2025
  • Table 61 : Middle East & Africa Drug Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
  • Table 62 : Middle East & Africa Gene Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
  • Figure 1 : Global Drug and Gene Delivery System Market Snapshot
  • Figure 2 : Global Drug and Gene Delivery System Market Size (US$ Bn), by Route of Administration, 2016
  • Figure 3 : Global Drug and Gene Delivery System Market Size (US$ Mn), by Region, 2016 and 2025
  • Figure 4 : Global Drug and Gene Delivery System Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
  • Figure 5 : Global Drug and Gene Delivery System Market Value Share, by Type of Gene Delivery System (2016)
  • Figure 6 : Global Drug Delivery System Market Value Share, by Type of Drug Delivery System (2016)
  • Figure 7 : Global Drug and Gene Delivery System Market Value Share, by Application (2016)
  • Figure 8 : Global Drug and Gene Delivery Systems Market Value Share, by Drug Delivery System, 2016 and 2025
  • Figure 9 : Global Drug and Gene Delivery Systems Market Value Share, by Gene Delivery System, 2016 and 2025
  • Figure 10 : Global Drug and Gene Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Drug Delivery System: Intrauterine Implants, 2015–2025
  • Figure 11 : Global Drug and Gene Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Drug Delivery System: Prodrug Implants, 2015–2025
  • Figure 12 : Global Drug and Gene Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Drug Delivery System: Polymeric Drug Delivery, 2015–2025
  • Figure 13 : Global Drug and Gene Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Drug Delivery System: Targeted Drug Delivery, 2015–2025
  • Figure 14 : Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Gene Delivery System: Viral Gene Delivery, 2015–2025
  • Figure 15 : Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Gene Delivery System: Non-viral Gene Delivery, 2015–2025
  • Figure 16 : Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Gene Delivery System: Combined Hybrid Systems, 2015–2025
  • Figure 17 : Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Viral Gene Delivery: Adenovirus Vector, 2015–2025
  • Figure 18 : Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Viral Gene Delivery: Lentivirus Vector, 2015–2025
  • Figure 19 : Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Viral Gene Delivery: Retrovirus Vector, 2015–2025
  • Figure 20 : Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Viral Gene Delivery: Adeno-associated Virus Vector, 2015–2025
  • Figure 21 : Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Viral Gene Delivery: Sendai Virus Vector, 2015–2025
  • Figure 22 : Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Viral Gene Delivery: Herpes Simplex Virus Vector, 2015–2025
  • Figure 23 : Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Viral Gene Delivery: Others, 2015–2025
  • Figure 24 : Global Drug and Gene Delivery Systems Market Attractiveness, by Drug Delivery System, 2017–2025
  • Figure 25 : Global Drug and Gene Delivery Systems Market Attractiveness, by Gene Delivery System, 2017–2025
  • Figure 26 : Global Drug Delivery System Market Value Share Analysis, by Application, 2016 and 2025
  • Figure 27 : Global Gene Delivery System Market Value Share Analysis, by Application, 2016 and 2025
  • Figure 28 : Global Drug Delivery System Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Infectious Diseases, 2015–2025
  • Figure 29 : Global Drug Delivery System Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Oncology, 2015–2025
  • Figure 30 : Global Drug Delivery System Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Ophthalmology, 2015–2025
  • Figure 31 : Global Drug Delivery System Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Urology, 2015–2025
  • Figure 32 : Global Drug Delivery System Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Diabetes, 2015–2025
  • Figure 33 : Global Drug Delivery System Market Revenue (US$ Bn) and Y-o-Y Growth (%), by CNS, 2015–2025
  • Figure 34 : Global Drug Delivery System Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Others, 2015–2025
  • Figure 35 : Global Gene Delivery System Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Infectious Diseases, 2015–2025
  • Figure 36 : Global Gene Delivery System Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oncology, 2015–2025
  • Figure 37 : Global Gene Delivery System Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ophthalmology, 2015–2025
  • Figure 38 : Global Gene Delivery System Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Urology, 2015–2025
  • Figure 39 : Global Gene Delivery System Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diabetes, 2015–2025
  • Figure 40 : Global Gene Delivery System Market Revenue (US$ Mn) and Y-o-Y Growth (%), by CNS, 2015–2025
  • Figure 41 : Global Gene Delivery System Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
  • Figure 42 : Global Drug Delivery System Market Attractiveness, by Application, 2017–2025
  • Figure 43 : Global Gene Delivery System Market Attractiveness, by Application, 2017–2025
  • Figure 44 : Global Drug and Gene Delivery Systems Market Value Share, by Drug Delivery: Route of Administration, 2016 and 2025
  • Figure 45 : Global Gene Delivery Systems Market Value Share, by Route of Administration, 2016 and 2025
  • Figure 46 : Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Oral, 2015–2025
  • Figure 47 : Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Injectable, 2015–2025
  • Figure 48 : Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Inhalation, 2015–2025
  • Figure 49 : Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Transdermal, 2015–2025
  • Figure 50 : Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Ocular, 2015–2025
  • Figure 51 : Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Nasal, 2015–2025
  • Figure 52 : Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Topical, 2015–2025
  • Figure 53 : Global Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Oral, 2015–2025
  • Figure 54 : Global Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Injectable, 2015–2025
  • Figure 55 : Global Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Inhalation, 2015–2025
  • Figure 56 : Global Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Transdermal, 2015–2025
  • Figure 57 : Global Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Ocular, 2015–2025
  • Figure 58 : Global Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Nasal, 2015–2025
  • Figure 59 : Global Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Topical, 2015–2025
  • Figure 60 : Global Drug and Gene Delivery Systems Market Attractiveness, by Drug Delivery: Route of Administration, 2017–2025
  • Figure 61 : Global Drug and Gene Delivery Systems Market Attractiveness, by Gene Delivery: Route of Administration, 2017–2025
  • Figure 62 : Global Drug and Gene Delivery System Market Revenue (US$ Bn) Forecast, 2015–2025
  • Figure 63 : Global Drug and Gene Delivery System Market Value Share Analysis, by Region, 2016 and 2025
  • Figure 64 : Global Drug and Gene Delivery System Market Attractiveness, by Region, 2017–2025
  • Figure 65 : North America Drug and Gene Delivery System Market Size (US$ Bn) and Y-o-Y Growth (%), 2015–2025
  • Figure 66 : North America Drug Delivery System Market Attractiveness Analysis, by Country, 2017–2025
  • Figure 67 : North America Gene Delivery System Market Attractiveness Analysis, by Country, 2017–2025
  • Figure 68 : North America Drug Delivery System Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 69 : North America Gene Delivery System Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 70 : North America Drug and Gene Delivery System Market Value Share Analysis, by Drug Delivery System, 2016 and 2025
  • Figure 71 : North America Drug and Gene Delivery System Market Value Share Analysis, by Gene Delivery System, 2016 and 2025
  • Figure 72 : North America Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery, 2016 and 2025
  • Figure 73 : North America Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery, 2016 and 2025
  • Figure 74 : North America Drug Delivery System Market Value Share Analysis, by Application, 2016 and 2025
  • Figure 75 : North America Gene Delivery System Market Value Share Analysis, by Application, 2016 and 2025
  • Figure 76 : North America Drug Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
  • Figure 77 : North America Gene Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
  • Figure 78 : North America Drug and Gene Delivery System Market Attractiveness Analysis, by Application, 2017–2025
  • Figure 79 : North America Drug and Gene Delivery System Market Attractiveness Analysis, by Route of Administration, 2017–2025
  • Figure 80 : Europe Drug and Gene Delivery System Market Size (US$ Bn) and Y-o-Y Growth (%), 2015–2025
  • Figure 81 : Europe Drug Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
  • Figure 82 : Europe Gene Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
  • Figure 83 : Europe Drug Delivery System Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • Figure 84 : Europe Gene Delivery System Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • Figure 85 : Europe Drug and Gene Delivery System Market Value Share Analysis, by Drug Delivery System, 2016 and 2025
  • Figure 86 : Europe Drug and Gene Delivery System Market Value Share Analysis, by Gene Delivery System, 2016 and 2025
  • Figure 87 : Europe Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery, 2016 and 2025
  • Figure 88 : Europe Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery, 2016 and 2025
  • Figure 89 : Europe Drug Delivery System Market Value Share Analysis, by Application, 2016 and 2025
  • Figure 90 : Europe Gene Delivery System Market Value Share Analysis, by Application, 2016 and 2025
  • Figure 91 : Europe Drug Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
  • Figure 92 : Europe Gene Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
  • Figure 93 : Europe Drug Delivery System Market Attractiveness Analysis, by Application, 2017–2025
  • Figure 94 : Europe Gene Delivery System Market Attractiveness Analysis, by Route of Administration, 2017–2025
  • Figure 95 : Asia Pacific Drug and Gene Delivery System Market Size (US$ Bn) and Y-o-Y Growth (%), 2015–2025
  • Figure 96 : Asia Pacific Drug Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
  • Figure 97 : Asia Pacific Gene Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
  • Figure 98 : Asia Pacific Drug Delivery System Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • Figure 99 : Asia Pacific Gene Delivery System Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • Figure 100 : Asia Pacific Drug and Gene Delivery System Market Value Share Analysis, by Drug Delivery System, 2016 and 2025
  • Figure 101 : Asia Pacific Drug and Gene Delivery System Market Value Share Analysis, by Gene Delivery System, 2016 and 2025
  • Figure 102 : Asia Pacific Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery, 2016 and 2025
  • Figure 103 : Asia Pacific Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery, 2016 and 2025
  • Figure 104 : Asia Pacific Drug Delivery System Market Value Share Analysis, by Application, 2016 and 2025
  • Figure 105 : Asia Pacific Gene Delivery System Market Value Share Analysis, by Application, 2016 and 2025
  • Figure 106 : Asia Pacific Drug Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
  • Figure 107 : Asia Pacific Gene Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
  • Figure 108 : Asia Pacific Drug Delivery System Market Attractiveness Analysis, by Application, 2017–2025
  • Figure 109 : Asia Pacific Gene Delivery System Market Attractiveness Analysis, by Route of Administration, 2017–2025
  • Figure 110 : Latin America Drug and Gene Delivery System Market Size (US$ Bn) and Y-o-Y Growth (%), 2015–2025
  • Figure 111 : Latin America Drug Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
  • Figure 112 : Latin America Gene Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
  • Figure 113 : Latin America Drug Delivery System Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • Figure 114 : Latin America Gene Delivery System Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • Figure 115 : Latin America Drug and Gene Delivery System Market Value Share Analysis, by Drug Delivery System, 2016 and 2025
  • Figure 116 : Latin America Drug and Gene Delivery System Market Value Share Analysis, by Gene Delivery System, 2016 and 2025
  • Figure 117 : Latin America Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery, 2016 and 2025
  • Figure 118 : Latin America Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery, 2016 and 2025
  • Figure 119 : Latin America Drug Delivery System Market Value Share Analysis, by Application, 2016 and 2025
  • Figure 120 : Latin America Gene Delivery System Market Value Share Analysis, by Application, 2016 and 2025
  • Figure 121 : Latin America Drug Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
  • Figure 122 : Latin America Gene Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
  • Figure 123 : Latin America Drug and Gene Delivery System Market Attractiveness Analysis, by Application, 2017–2025
  • Figure 124 : Latin America Drug and Gene Delivery System Market Attractiveness Analysis, by Route of Administration, 2017–2025
  • Figure 125 : Middle East & Africa Drug and Gene Delivery System Market Size (US$ Bn) and Y-o-Y Growth (%), 2015–2025
  • Figure 126 : Middle East & Africa Drug Delivery System Market Attractiveness Analysis, by Country/Sub-Region, 2017–2025
  • Figure 127 : Middle East & Africa Gene Delivery System Market Attractiveness Analysis, by Country/Sub-Region, 2017–2025
  • Figure 128 : Middle East & Africa Drug Delivery System Market Value Share Analysis, by Country/Sub-Region, 2016 and 2025
  • Figure 129 : Middle East & Africa Gene Delivery System Market Value Share Analysis, by Country/Sub-Region, 2016 and 2025
  • Figure 130 : Middle East & Africa Drug and Gene Delivery System Market Value Share Analysis, by Drug Delivery System, 2016 and 2025
  • Figure 131 : Middle East & Africa Drug and Gene Delivery System Market Value Share Analysis, by Gene Delivery System, 2016 and 2025
  • Figure 132 : Middle East & Africa Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery, 2016 and 2025
  • Figure 133 : Middle East & Africa Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery, 2016 and 2025
  • Figure 134 : Middle East & Africa Drug Delivery System Market Value Share Analysis, by Application, 2016 and 2025
  • Figure 135 : Middle East & Africa Gene Delivery System Market Value Share Analysis, by Application, 2016 and 2025
  • Figure 136 : Middle East & Africa Drug Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
  • Figure 137 : Middle East & Africa Gene Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
  • Figure 138 : Middle East & Africa Drug and Gene Delivery System Market Attractiveness Analysis, by Application, 2017–2025
  • Figure 139 : Middle East & Africa Drug and Gene Delivery System Market Attractiveness Analysis, by Route of Administration, 2017–2025

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us